运营 来源:作者:申少铁 时间:2023-06-09 03:34:05
(资料图片)
记者从国家卫健委获悉:2023年6月8日,经国家相关部门批准川大华西/威斯克生物研发的重组三价新冠病毒(XBB+BA.5+Delta变异株)三聚体蛋白疫苗(Sf9细胞)--威克欣®3价XBB疫苗纳入紧急使用,这是全球首个获批紧急使用的针对XBB等变异株的新冠疫苗,预计未来1-2月,公众可接种该疫苗。
图片来源:四川大学华西医院微博
标签:
下一篇:最后一页
23-06-08
23-06-08
23-06-08
23-06-08
23-06-08
23-06-08
23-06-08
23-06-08
23-06-08
23-06-08
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
22-09-30
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09
23-06-09